Comparison of Omeprazol blood level in granule & syrup form in children by high performance liquid chromatography (HPLC)

Phase 3

• Conditions: Condition 1: Acid peptic disease. Condition 2: Acid peptic disease.; Oesophagitis; Gastritis and duodenitis

• Registration Number: IRCT201009154746N1
• Lead Sponsor: Shiraz university of medical sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

Patient with acid peptic disease who needed Omeprazol.

Exclusion Criteria

Blood sample not available.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Omeprazol blood level. Timepoint: 0.5 hour before dosing and 2 houre affter dosing. Method of measurement: HPLC System.

Secondary Outcome Measures

Name	Time	Method
Clinical effect. Timepoint: 2 weeks. Method of measurement: by physician.